Lipoic acid offers no improvements in walking speed or other outcomes in patients with progressive multiple sclerosis ...

Students face harmful myths about accommodations despite extensive barriers to support. The backlash stems from ableist ...

Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosisParis, December 24, 2025.

A simple test can reveal whether someone unknowingly lives with a hidden disability known as aphantasia – a condition that ...

Is an intellectual disability a condition, or a number on an IQ test? Here's why an Alabama death penalty case at the Supreme ...

The Supreme Court is considering an appeal from Alabama that could lower standards for determining intellectual disability in ...

Higher education’s maximally inclusive approach to disability is resulting in a two-speed student population and ...

As high schools rethink graduation requirements, a growing number are moving away from requiring all students to pass a comprehensive test.

Sanofi provides update on tolebrutinib in primary progressive multiple sclerosisPERSEUS phase 3 study in primary progressive multiple sclerosis ...

The Supreme Court will hear arguments Wednesday in a case that could make it harder for convicted murderers to show their lives should be spared because they are intellectually disabled.

GFAP and NfL blood levels help track MS disease activity and disability progression. NfL is linked to relapse risk, while GFAP signals disability progression (PIRA). Using both markers may help ...